Volitionrx Limited (VNRX) to Offer Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/16/2026
- Wall St futures pause after two-day rally as investors await data, earnings
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- U.S. headline producer inflation posts first one-month decrease since August 2025
- Oil eases as traders weigh US-Iran conflict risks
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
Volitionrx Limited (VNRX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
February 10, 2021 9:23 AM ESTVolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of cancers and other diseases, announced the pricing of its underwritten public offering of 3,809,524 shares of its common stock (the "Offering") for gross proceeds of... More
